Tocilizumab Treatment in Graves´ Ophthalmopathy (Graves´ Orbitopathy or Thyroid Eye Disease)
Phase 3
Completed
- Conditions
- Thyroid Associated OphthalmopathiesGraves´ OphthalmopathyThyroid Eye Disease
- Interventions
- Drug: Sterile 0.9% Sodium Chloride
- First Posted Date
- 2011-02-17
- Last Posted Date
- 2016-01-20
- Lead Sponsor
- Hospital Clinico Universitario de Santiago
- Target Recruit Count
- 32
- Registration Number
- NCT01297699
- Locations
- 🇪🇸
Hospital Universitario Virgen del Rocío, Sevilla, Spain
🇪🇸Hospital Clínico de Santiago, Santiago de Compostela, A Coruña, Spain
🇪🇸Hospital Clínico San Carlos, Madrid, Spain
© Copyright 2025. All Rights Reserved by MedPath